Literature DB >> 23440559

The neuropsychiatric and neuropsychological features of chronic fatigue syndrome: revisiting the enigma.

Yvonne Christley1, Tim Duffy, Ian Paul Everall, Colin R Martin.   

Abstract

The aim of this article is to provide a comprehensive and updated review of the key neuropsychiatric and neuropsychological complaints associated with chronic fatigue syndrome (CFS). Neuropsychiatric and neuropsychological difficulties are common in CFS and are linked primarily to disorders of mood, affect and behaviour. The neuropsychiatric complaint most frequently encountered amongst CFS patients is depression and in particular major depressive disorder (MDD). Despite decades of research, the precise aetiological relationship between CFS and MDD remains poorly understood. This has resulted in the development of a number of interesting and polarised hypotheses regarding the aetiological nature of CFS. Recent scientific advances have however begun to unravel a number of interesting inflammatory and immunological explanations that suggest CFS and MDD are distinct yet interrelated conditions. The possibility that the overlap between CFS and MDD might be explained in terms of shared oxidative and nitrosative (IO&NS) pathways is an area of intense research interest and is reviewed in detail in this article. The overlap between CFS and MDD is further differentiated by variations in HPA axis activity between the two disorders. Important immunological differences between MDD and CFS are also reviewed with particular emphasis on antiviral RNase L pathways in CFS. In addition to the presence of neuropsychiatric complaints, CFS is also associated with neuropsychological symptoms such as impaired attention, memory and reaction time. The key neuropsychological problems reported by CFS patients are also included in the review in an effort to understand the significance of cognitive impairment in CFS.

Entities:  

Mesh:

Year:  2013        PMID: 23440559     DOI: 10.1007/s11920-013-0353-8

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  79 in total

Review 1.  Neurobiological mechanisms in generalized anxiety disorder.

Authors:  D J Nutt
Journal:  J Clin Psychiatry       Date:  2001       Impact factor: 4.384

2.  Cognitive processing in monozygotic twins discordant for chronic fatigue syndrome.

Authors:  Roderick K Mahurin; Keith H Claypoole; Jack H Goldberg; Lester Arguelles; Suzanne Ashton; Dedra Buchwald
Journal:  Neuropsychology       Date:  2004-04       Impact factor: 3.295

Review 3.  Psychiatric aspects of chronic fatigue syndrome and fibromyalgia.

Authors:  Boudewijn Van Houdenhove; Stefan Kempke; Patrick Luyten
Journal:  Curr Psychiatry Rep       Date:  2010-06       Impact factor: 5.285

Review 4.  The neuroendocrinology of chronic fatigue syndrome.

Authors:  Anthony J Cleare
Journal:  Endocr Rev       Date:  2003-04       Impact factor: 19.871

5.  Psychological symptoms, somatic symptoms, and psychiatric disorder in chronic fatigue and chronic fatigue syndrome: a prospective study in the primary care setting.

Authors:  S Wessely; T Chalder; S Hirsch; P Wallace; D Wright
Journal:  Am J Psychiatry       Date:  1996-08       Impact factor: 18.112

6.  Assessing somatization disorder in the chronic fatigue syndrome.

Authors:  S K Johnson; J DeLuca; B H Natelson
Journal:  Psychosom Med       Date:  1996 Jan-Feb       Impact factor: 4.312

7.  Chronic fatigue and chronic fatigue syndrome: clinical epidemiology and aetiological classification.

Authors:  P Manu; T J Lane; D A Matthews
Journal:  Ciba Found Symp       Date:  1993

8.  Screening for somatization disorder in patients with chronic fatigue.

Authors:  P Manu; T J Lane; D A Matthews; J I Escobar
Journal:  Gen Hosp Psychiatry       Date:  1989-07       Impact factor: 3.238

9.  Cognitive functioning in chronic fatigue syndrome: a meta-analysis.

Authors:  S J Cockshell; J L Mathias
Journal:  Psychol Med       Date:  2010-01-05       Impact factor: 7.723

10.  A comparison of neuropsychiatric characteristics in chronic fatigue syndrome, multiple sclerosis, and major depression.

Authors:  C M Pepper; L B Krupp; F Friedberg; C Doscher; P K Coyle
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1993       Impact factor: 2.198

View more
  6 in total

1.  Meta-analysis investigating post-exertional malaise between patients and controls.

Authors:  Abigail Brown; Leonard A Jason
Journal:  J Health Psychol       Date:  2018-07-05

Review 2.  Cognitive Dysfunction in Chronic Fatigue Syndrome: a Review of Recent Evidence.

Authors:  Erin Cvejic; Rachael C Birch; Uté Vollmer-Conna
Journal:  Curr Rheumatol Rep       Date:  2016-05       Impact factor: 4.592

3.  Evidence in chronic fatigue syndrome for severity-dependent upregulation of prefrontal myelination that is independent of anxiety and depression.

Authors:  Leighton R Barnden; Benjamin Crouch; Richard Kwiatek; Richard Burnet; Peter Del Fante
Journal:  NMR Biomed       Date:  2015-03       Impact factor: 4.044

4.  Polymorphism in COMT is associated with IgG3 subclass level and susceptibility to infection in patients with chronic fatigue syndrome.

Authors:  Madlen Löbel; Agnes Anna Mooslechner; Sandra Bauer; Sabrina Günther; Anne Letsch; Leif G Hanitsch; Patricia Grabowski; Christian Meisel; Hans-Dieter Volk; Carmen Scheibenbogen
Journal:  J Transl Med       Date:  2015-08-14       Impact factor: 5.531

5.  Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.

Authors:  Madlen Loebel; Maren Eckey; Franziska Sotzny; Elisabeth Hahn; Sandra Bauer; Patricia Grabowski; Johannes Zerweck; Pavlo Holenya; Leif G Hanitsch; Kirsten Wittke; Peter Borchmann; Jens-Ulrich Rüffer; Falk Hiepe; Klemens Ruprecht; Uta Behrends; Carola Meindl; Hans-Dieter Volk; Ulf Reimer; Carmen Scheibenbogen
Journal:  PLoS One       Date:  2017-06-12       Impact factor: 3.240

Review 6.  Chronic fatigue syndrome and quality of life.

Authors:  Deb Roberts
Journal:  Patient Relat Outcome Meas       Date:  2018-08-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.